|
| |
 |
|
| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 12
| Issue : 2 | Page : 69-77 |
|
Anti-tumor effects and cellular mechanisms of Pistacia atlantica methanolic extract against Ehrlich solid tumor in mice
Aishah E Albalawi1, Norah A Althobaiti2, Reem Hasaballah Alhasani3, Sultan F Alnomasy4
1 Faculty of Science, Department of Biology, University of Tabuk, Tabuk 47913, Saudi Arabia
2 Biology Department, College of Science and Humanities, Al Quwaiiyah, Shaqra University, Al Quwaiiyah 19257, Saudi Arabia
3 Department of Biology, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
4 Department of Medical Laboratories Sciences, College of Applied Medical Sciences, Al-Quwayiyah, Shaqra University, Riyadh, Saudi Arabia
| Date of Submission | 07-Nov-2021 |
| Date of Decision | 03-Dec-2021 |
| Date of Acceptance | 22-Dec-2021 |
| Date of Web Publication | 21-Jan-2022 |
Correspondence Address:
Sultan F Alnomasy
Department of Medical Laboratories Sciences, College of Applied Medical Sciences, Al-Quwayiyah, Shaqra University, Riyadh
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | 3 |
DOI: 10.4103/2221-1691.335695
Objective: To assess the anti-tumor effects of Pistacia atlantica methanolic extract (PAME) compared with cyclophosphamide against Ehrlich solid tumors in mice.
Methods: Swiss albino mice (n=40) were divided into five groups: normal control mice, mice with Ehrlich solid tumors treated with normal saline, mice with Ehrlich solid tumors treated with cyclophosphamide intraperitoneally once a day for 14 d, or 50 mg/kg or 100 mg/kg PAME orally once a day for 14 d. Tumor growth inhibition, body weight, tumor markers, liver and kidney enzymes, oxidative stress markers, antioxidant enzymes, tumor necrosis factor-alpha level (TNF-α), and apoptosis-regulatory gene expression were evaluated.
Results: Treatment of mice bearing Ehrlich solid tumors with PAME at 50 and 100 mg/kg orally significantly decreased tumor volume, body weight, tumor markers, liver and kidney enzymes, oxidative stress markers and TNF-α level in comparison with mice with Ehrlich solid tumors receiving normal saline. whereas PAME at 50 and 100 mg/kg/day significantly elevated the level of antioxidant enzymes (P<0.05).
Conclusions: Pistacia atlantica methanolic extract has potent antitumor activity in mice. Therefore, the extract might be considered as an alternative anticancer agent against tumors, however, additional studies especially in the clinical setting are required to confirm this finding. Keywords: Cancer; Ehrlich solid tumors; Treatment; Pistacia atlantica; Herbal medicines; Natural product; in vivo; Mice
How to cite this article:
Albalawi AE, Althobaiti NA, Alhasani RH, Alnomasy SF. Anti-tumor effects and cellular mechanisms of Pistacia atlantica methanolic extract against Ehrlich solid tumor in mice. Asian Pac J Trop Biomed 2022;12:69-77 |
How to cite this URL:
Albalawi AE, Althobaiti NA, Alhasani RH, Alnomasy SF. Anti-tumor effects and cellular mechanisms of Pistacia atlantica methanolic extract against Ehrlich solid tumor in mice. Asian Pac J Trop Biomed [serial online] 2022 [cited 2023 Jun 4];12:69-77. Available from: https://www.apjtb.org/text.asp?2022/12/2/69/335695 |
| 1. Introduction | |  |
Among the many diseases that threaten human health and life, cancer is one of the most important reasons for death in the world[1]. The disease is characterized by the disruption of the normal cell cycle, which causes unplanned cell growth and subsequently the absence of differentiation, characterized as malignant developments[2]. Chemotherapy has long been one of the most important cancer therapies, which can be used alone or in combination with other treatments, such as surgical processes and radiotherapies[3]. At present, a wide range of chemical drugs are used to prevent and treat various types of cancers; however, the studies demonstrated that the current synthetic medications are accompanied by some adverse side effects such as damage to the normal tissues and cells, inhibition of bone marrow function, nausea, vomiting, alopecia, etc[4],[5]. Therefore, the search for a new anticancer drug, especially from high-performance and low-toxicity sources, has always been of interest to researchers. In recent years, herbs and their derivatives and products have attracted attention due to their high effectiveness, low toxicity, availability, and cheapness, as alternative drugs in the treatment of cancers[6],[7].
Wild pistachio [Pistacia atlantica (P. atlantica) Desf.], from the Anacardiaceae family, broadly grows in central Asia, particularly in Saudi Arabia, Syria, etc[8]. The plant has various therapeutic potential as traditional medicine and is used to treat or improve some diseases and conditions such as digestive problems, vomiting, diuretic, demulcent, dyspepsia, skin diseases, wound healing, disorders of liver and kidney, gastrointestinal disorders, toothache diseases, etc[9]. In addition, it also has several other pharmacological properties such as antinociceptive, antidiabetic, anti-inflammatory, antiproliferative, hepatoprotective, antioxidant, immunomodulatory, antimicrobial, etc[9],[10]. Several studies also have reported the in vitro and in vivo anticancer activity of different parts of this plant against colonic adenocarcinoma (COLO205), human gastric carcinoma (AGS), human colorectal adenocarcinoma cell (HT29 cells), cervix adenocarcinoma (HeLa cells), etc[10],[11],[12]. The Ehrlich tumor as a murine mammary adenocarcinoma is a solid form of the tumor which is broadly used in the assessment of efficacy and innovation of new anti-tumor agents[13],[14]. The current survey was designed to assess the anti-tumor effects of P. atlantica methanolic extract (PAME) compared with cyclophosphamide (CP) against the Ehrlich solid tumors (EST) in mice.
| 2. Materials and methods | | |
2.1. Reagents and drugs
All chemicals, Folin-Ciocalteau’s reagent, as well as Mayer and Dragendorff’s were obtained from Sigma-Aldrich (St. Louis, MO). MyBio-Source Mice Carcinoembryonic Antigen Elisa Kit was obtained from MyBio-Source, San Diego, USA. Liver and kidney enzymes kits were prepared from Roche, Germany. The mini-VIDAS® AFP kit was prepared from bioMérieux, Marcyl’Etoile, France. The oxidative stress kits, the antioxidant enzymes kits, and TNF-α ELISA kit were purchased from Abcam, USA. RNeasy tissue kit and the complementary DNA (cDNA) synthesis kit were prepared from Qiagen Co, Germany. All the chemicals used were of analytical grade.
2.2. Plant material
Fruits of P. atlantica were purchased from a marketplace in Riyadh city, Saudi Arabia and after being determined by a botanist, a sample of voucher was deposited at the herbarium of Shaqra University, Saudi Arabia for further experiments.
2.3. Preparation of methanolic extract
By percolation method, 200 g of the dried fruits were extracted with methanol for 72 h at 21 °C. Next, the obtained extracts were passed over a filter paper and were evaporated by a rotary evaporator in a vacuum at 55 °C and preserved at -20 °C until examination[15].
2.4. Phytochemical analysis
The primary phytochemical analysis of the PAME was done to test alkaloids, tannins, glycosides, saponins, and flavonoids, including Mayer and Dragendorff’s reagents to identify the alkaloids, Mg and HCl for identification of flavonoids, 1% gelatin along with 10% NaCl solutions to determine the tannin, the combination of FeCl2 and H2SO4 to examine the glycosides, and saponin determined by the capacity to produce suds[16].
2.4.1. Total phenol content
Total phenol content was studied using the Folin-Ciocalteau’s reagent colorimetric method using gallic acid as a standard[17]. In brief, 0.2 mL of PAME was added to Folin-Ciocalteu solution and then 2 mL of sodium carbonate was added to the combination. Followed by the incubation (30 min) in the darkness, the absorbance of the mixture was recorded at 760 nm using a spectrophotometer (Jenway 6715, Cole-Parmer, Eaton Socon, UK); the results were described as mg gallic acid (GAE)/g dry weight.
2.4.2. Total flavonoid content
The content of total flavonoid was assessed based on the technique explained by Phuyal et al.[18] using aluminum chloride (AlCl3 2%) colorimetric and quercetin as a standard. Briefly, 0.2 mL of extract or standard solution was added to 0.2 mL of aluminum chloride and 0.1 mL of 33% aqueous acetic acid and stirred well. In the end, the combination was reached a volume of 5 mL with ethanol. Lastly, the absorbance was measured at 430 nm and the total flavonoid was gained through a standard curve as mg quercetin equivalent per gram dry weight (mg QE/g DW).
2.4.3. Tannin condensed contents
The method described by Broadhurst and Jones[19] was used to determine the tannin condensed contents of PAME. After mixing the extract and control with vanillin-HCl (5 mL), the absorbance was measured at 510 nm. The content was presented as mg catechin (CE)/g DW.
2.5. Anti-tumor effects of PAME
2.5.1. Animals
Fifty-six female Swiss albino mice weighing 20-25 g and aged 6–8 weeks old were used to establish the animal model of EST. Mice were held in a colony room under a 12:12 h light/ dark cycle at (21 ± 2) °C with ad libitum access to food and water.
2.5.2. The Ehrlich ascites tumor cell line and induction of EST in mice
The cell line of the Ehrlich ascites tumor was prepared from the American Type Tissue Culture Collection (Manassas, USA) and was adjusted into 2.5×106 cells/mL in sterile saline solution using a Neubauer hemocytometer.
2.5.3. Study design
Swiss albino mice were divided into seven groups (8 mice per group). At first, EST was established in 32 mice by intramuscular injection of 200 μL of cells (2.5×106 cells/mL) in the right thigh of mice[20]. On the 5th day after the EST inoculation, the mice were randomly divided into groups including non-EST mice receiving normal saline (C1), EST mice receiving normal saline (C2), EST mice treated with cyclophosphamide (CP) (5 mg/kg) intraperitoneally once a day for 14 d (C3), EST mice treated with PAME 50 mg/kg orally once a day for 2 weeks (Ex1), and EST mice treated with PAME 100 mg/kg orally once a day for 2 weeks (Ex2). The selection of doses of PAME was based on the pilot experiments and previous study[21]. Furthermore, two groups of healthy mice were used to evaluate the sub-acute toxicity of PAME including mice treated with PAME 50 mg/kg orally once a day for 2 weeks (C4), mice treated with PAME 100 mg/kg orally once a day for 2 weeks (C5)[13].
2.5.4. Blood sampling
At first, the mice were euthanized with ketamine (100 mg/kg) along with xylazine (10 mg/kg). Then, their abdomen cavities were opened. Blood samples were obtained from the heart of mice. After centrifuging the blood samples at 6 000 rpm for 10 min, the obtained sera were separated and kept at −80 °C until examination.
2.5.5. Body weight changes
Mice were weighed on day 5 and day 19. The percentage of the obtained weight was assessed using the equation[21]: %weight gain = (Mice weight on 19th day/Mice weight on 5th day-1)×100.
2.5.6. Tumor sampling
After sterile aseptically removing of tumors in mice of C2, C3, Ex1, and Ex2 groups, they were weighed, and their dimensions were recorded. For further analysis, tumors were equally divided into two parts: the first part was kept at −80 °C for molecular tests, and the second part was kept at − 20 °C for other tests.
2.5.7. Tumor growth inhibition
The antitumor activity of PAME was measured by calculating the tumor volume and tumor growth inhibition rate. Tumor volume was calculated by the vernier caliper after the 7th day of the treatment by the equation: tumor volume (mm3) = 4 (A/2)2 (B/2). So that, A and B are the small and big tumor axes. Tumor growth inhibition rate was determined based on the below formula:
Tumor growth inhibition rate (%)= (The mean tumor weight of control group-the mean tumor weight of treated group)/The mean tumor weight of control group C2×100[13].
2.5.8. Evaluation of the tumor markers
The level of alpha-fetoprotein (AFP) was determined using a mini-VIDAS® AFP kit based on the manufacturer’s protocols. In addition, the serum level of carcinoembryonic antigen (CEA) was also evaluated by MyBio-Source Mice Carcinoembryonic Antigen Elisa Kit.
2.5.9. Evaluation of serum levels of liver enzymes
Serum levels of some liver enzymes including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in mice of all groups were measured using the commercial diagnostic kits[22].
2.5.10. Evaluation of serum levels of kidney enzymes
The level of serum creatinine (Cr) and blood urea nitrogen (BUN) were determined in mice of all groups using the commercial diagnostic kits[22].
2.6. Cellular mechanisms
2.6.1. Evaluation of the oxidative stress markers
To evaluate the lipid peroxidation, tumor homogenates were studied by biodiagnostic analysis kits based on the malondialdehyde (MDA) production using the thiobarbituric acid (TBA) methodology explained by of El-Aarag et al.[23]; in addition, NO production (Abcam, USA) was measured in the hepatic suspension technique defined by Green et al.[24]. Briefly, in this method, the thiobarbituric acid reacts with MDA in the liver homogenate to produce a thiobarbituric acid reactive product. Then, the absorbance was calculated at 534 nm.
2.6.2. Evaluation of the antioxidant enzymes
The levels of some enzymes involved in antioxidant activities such as glutathione peroxidase (GPx), catalase enzyme (CAT), and superoxide dismutase enzyme (SOD) activities were determined using the commercial kits and based on the method described by Weydert[25], El-Aarag[26], and Sun et al.[27], respectively.
2.6.3. Measurement of tumor necrosis factor-alpha (TNF-α) level
TNF-α levels in tumor homogenates were examined by the mice TNF-α ELISA kit based on the manufacturer’s protocol.
2.6.4. Evaluation of the apoptosis-regulatory gene expression
The expression levels of some apoptosis-regulatory genes such as caspase-3, Bcl-2, and Bax were evaluated by the quantitative real-time PCR. In brief, the total RNA of tumor tissue was extracted by an RNeasy tissue kit based on the guidelines of the manufacturer. The cDNA was synthesized using the random primers according to the manufacturer’s instructions. The synthesized cDNA was then used for real-time PCR by SYBR green. The thermal program of reaction was 96 °C for 7 min, 40 cycles of 95 °C for 10 s, and 56 °C for 30 s, respectively. Lastly, the 2 −ΔΔCt was calculated using the iQTM5 optical system software (Bio-Rad, Hercules, CA). The housekeeping gene was β-actin. [Table 1] displays oligonucleotide primers which were used for real-time PCR[28].
2.7. Statistical analysis
The obtained data were presented as mean ± standard deviation. SPSS statistical software version, 22.0 (SPSS Inc., Chicago, IL, USA) was used for analysis. One-way ANOVA with Turkey’s post hoc test was used to assess differences between experimental groups.
2.8. Ethical statement
This study was approved by the Ethical Committee of Scientific Research, Al-Quwayiyah, Shaqra University, Saudi Arabia (No. 20201123).
| 3. Results | | |
3.1. Phytochemical analysis
The results exhibited the existence of a high volume of tannins, terpenoids, glycosides, and flavonoids as well as the lack of the alkaloids and saponins in the tested herb.
3.2. Secondary metabolites contents
The results showed that the total flavonoid, phenolic, and tannin content was 3.68 (mg QE/g DW), 74.6 (mg GEA/g DW), and 2.34 (mg CE/g DW), respectively.
3.3. Body weight evaluation
[Figure 1] demonstrates that EST mice treated with CP and PAME at 50 and 100 mg/kg showed a significant decline in body weight (P<0.05) when compared with that of untreated EST mice in the C2 control group. | Figure 1: Mean of % of weight gains. C1: non-Ehrlich solid tumors (EST) and non-treated mice; C2: EST mice receiving normal saline; C3: EST mice treated with cyclophosphamide; C4: healthy mice receiving the PAME at a dose of 50 mg/kg; C5: healthy mice receiving the PAME at a dose of 100 mg/kg; Ex1: EST mice treated with PAME 50 mg/kg; Ex2: EST mice treated with PAME 100 mg/kg. Data are expressed as mean±SD. +: P<0.001, significant difference compared with the C2 group.
Click here to view |
3.4. Tumor growth inhibition
Compared with the C2 group [(2.86±0.12) g], treatment wtih PAME significantly decreased the tumor volume in a dose-dependent manner in EST mice (P<0.05) [50 mg/kg: (1.93±0.07) g, 100 mg/kg: (1.12±0.05) g]. The tumor inhibition rate was 32.5% and 60.8% after treatment with PAME at 50 and 100 mg/kg, respectively.
3.5. Evaluation of tumor markers
The results revealed that in the C2 group, the serum level of CEA and AFP was significantly elevated compared with the C1 group (P<0.001). As shown in [Figure 2], the level of CEA and AFP was significantly declined in mice bearing EST treated with CP and PAME at 50 and 100 mg/kg when compared with the mice of the C2 group (P<0.001). | Figure 2: Serum level of alpha-fetoprotein (AFP) (A) and carcinoembryonic antigen (CEA) (B). Data are expressed as mean±SD. #P<0.001 significant difference compared with the C1 group; +P<0.001 significant difference compared with the C2 group.
Click here to view |
3.6. Evaluation of serum level of liver enzymes
As shown in [Figure 3], the serum level of AST and ALT was significantly increased in the control group of C2 (P<0.001); whereas CP and PAME at 50 and 100 mg/kg significantly reduced the level of ALT and AST (P<0.001) compared with the C2 group. The findings also exhibited that after the oral administration of healthy mice with PAME at 50 (C4) and 100 (C5) mg/kg for 14 d, the levels of AST and ALT showed no significant difference compared with the control group C1. | Figure 3: Serum level of (A) aspartate aminotransferase (AST) and (B) alanine aminotransferase (ALT). Data are expressed as mean±SD. #P<0.001 significant difference compared with the C1 group; +P<0.001 significant difference compared with the C2 group.
Click here to view |
3.7. Evaluation of serum level of kidney enzymes
[Figure 4] demonstrates that the serum level of BUN and Cr was significantly increased in the control group of C2; whereas CP and PAME at 50 and 100 mg/kg significantly reduced the level of BUN and Cr (P<0.001) compared with the mice of the C2 group. The findings also exhibited that after the oral administration of healthy mice with PAME at 50 (C4) and 100 (C5) mg/kg for 14 d, the level of BUN and Cr showed no significant difference in comparison with the control group C1. | Figure 4: Serum level of (A) blood urea nitrogen (BUN) and (B) creatinine (Cr). Data are expressed as mean±SD. #P<0.001 significant difference compared with the C1 group; +P<0.001 significant difference compared with the C2 group.
Click here to view |
3.8. Evaluation of the oxidative and antioxidant markers
As shown in [Figure 5], the level of tumor MDA and NO was significantly elevated in the C2 group; while CP and PAME at 50 and 100 mg/kg/day significantly reduced MDA and NO (P<0.05). The level of GPx, CAT, and SOD was significantly declined in the C2 group. However, PAME at 50 and 100 mg/kg/day significantly increased the level of GPx, CAT, and SOD (P<0.05). | Figure 5: Tumor level of the malondialdehyde (MDA) and nitric oxide (NO), glutathione peroxidase (GPx), catalase enzyme (CAT), and superoxide dismutase enzyme activity (SOD). Data are expressed as mean±SD. #P<0.001 significant difference compared with the C1 group; +P<0.05 significant difference compared with the C2 group.
Click here to view |
3.9. Measurement of the TNF-α level
The results exhibited that the level of TNF-α in mice of the C2 control group was significantly increased; whereas treatment with CP and PAME at 50 and 100 mg/kg/day significantly decreased the level of TNF-α in mice (P<0.05) [Figure 6]. | Figure 6: TNF-α level. Data are expressed as mean±SD. #P<0.001 significant difference compared with the C1 group; +P<0.05 significant difference compared with the C2 group.
Click here to view |
3.10. Evaluation of the apoptosis-regulatory gene expression
The expression of the caspase-3 gene was significantly up-regulated in tumor tissues (P<0.001), with 3.21-, 2.58- and 3.10-fold after treatment of CP and PAME at 50 and 100 mg/kg, respectively. The expression of the Bax gene was also significantly (P<0.001) up-regulated in tumor tissues (P<0.001), by 3.42-, 2.79-and 3.60- fold after treatment of CP and PAME at 50 and 100 mg/ kg, respectively. The expression level of Bcl-2 was downregulated after treatment of PAME.
| 4. Discussion | | |
In many parts of the world, cancer is the 2nd principal reason for death after cardiovascular disease. Current problems in the use of chemotherapy and radiation therapy and the numerous side effects, as well as the resistance of cancer cells to common therapies, have led researchers to tend to new drugs with greater effectiveness and less toxicity[1],[2],[3]. Nature is an amazing source of suitable new drug compounds with great chemical diversity[29],[30]. Therefore, in the present study, we aimed to evaluate the anti-tumor effects of PAME against the Ehrlich ascites carcinoma as a spontaneous breast carcinoma model in mice.
Our findings revealed that treatment of mice bearing EST with PAME at 50 and 100 mg/kg significantly decreased the tumor weight and volume. Moreover, tumor inhibition rate was 32.5% and 60.8%, respectively. Considering the anticancer activity of P. atlantica, Shafiei et al. have demonstrated cytotoxic effects of P. atlantica gum resin against human bile duct cancer (CC50 value of 15.3 μg/mL), pancreatic carcinoma (CC50 value of 11.5 μg/mL), gastric adenocarcinoma (CC50 value of 8.1 μg/mL), and COLO205 cells (CC50 value of 5.2 μg/mL)[12]. In the other study, Hashemi et al. have reported the cytotoxic effects of P. atlantica ethanolic extract against AGS (IC50 value of 382 μg/mL) and HeLa cells (IC50 value of 332 μg/mL)[31].
Today, serum levels of AFP and CEA are considered as the main tumor markers that become raised during some cancers development[32]. The elevation of these markers might indicate the liver and renal damage induced by the invasion of cancer cells. Our results demonstrated that the serum levels of CEA and AFP were significantly increased in the control group of C2, while PAME at 50 and 100 mg/kg significantly reduced the level of CEA and AFP (P<0.001).
Studies demonstrated that the cancer cells interrupted the metabolism of the normal liver cell which elevated the activity of serum enzymes, the destruction of hepatocytes by the invasion of cancer cells results in the release of AST and ALT into the plasma and subsequently the elevation of these liver enzymes[33]. In line with previous studies[34],[35], we found that the serum level of AST and ALT was significantly increased in mice bearing EST, indicating that EST results in severe hepatocellular damage. However, treatment of PAME at 50 and 100 mg/kg significantly reduced the level of ALT and AST (P<0.001).
Previous studies have demonstrated that EST impairs renal function and results in increasing blood BUN and Cr[36]. Similarly, we found that the serum level of BUN and Cr was significantly increased in mice bearing EST; whereas PAME at 50 and 100 mg/ kg significantly reduced the level of BUN and Cr (P<0.001).
It has been proven that oxidative stress is mainly involved in the development of cancers and cardiovascular diseases[37]. Nowadays, studies demonstrated that antioxidants derived from natural products are potentially able to protect human beings from damages due to oxidative stress[38]. Our findings revealed that the levels of tumor MDA and NO were significantly elevated in the C2 group, which are significantly (P<0.05) reduced by PAME at 50 and 100 mg/kg. The levels of GPx, CAT, and SOD were significantly declined in the C2 group, which were significantly (P<0.05) increased by PAME at 50 and 100 mg/kg. In line with the current results, several studies reported the antioxidant effects of various parts of P. atlantica by DPPH-based radical scavenging, nitric oxide scavenging, β-carotene bleaching tests, etc[10],[39]. Previous investigations have shown that the potent antioxidant effect of the plant is due to the presence of some phenolic (e.g. galloylquinic acid, quinic acid, gallic acid) and terpenes compounds whose antioxidant effects have already been proven[10],[40].
Cancer cells can lead to serious damage as well as hypoxia in normal tissues, not only by physically damaging the cells but also by stimulating the production of some pro-inflammatory cytokines[41]. The results of the present study are similar to the previous study[42]. The level of pro-inflammatory cytokine TNF-α in EST mice was significantly increased; whereas treatment of PAME at 50 and 100 mg/kg significantly (P<0.05) decreased the level of TNF-α in mice. The main mechanism is its ability to scavenge free radicals as well as its anti-inflammatory effect[43].
Programmed-cell death which also called “apoptosis” is a form of cell death that occurs in response to various stressors such as physiological, pathological, or cytotoxic stimuli in the body. Apoptosis plays a role in different stages of a living organism’s biological evolution and can cause various diseases if it is out of control[44]. One of the main processes in tumorigenesis and cancers is the inhibition of apoptosis which is vital for cancer cells to keep their uncontrollable multiplying. Consequently, induction of apoptosis is considered a main approach to treating cancer[45].
In this study, the expression level of some apoptotic genes (caspase-3, Bcl-2, and Bax) in tumor tissues was evaluated by quantitative real-time PCR. Our findings exhibited the expression of caspase-3 and Bax gene was significantly increased in tumor tissues (P<0.001) after treatment of PAME at 50 and 100 mg/ kg. In contrast, the expression level of Bcl-2 was downregulated. Similarly, in the study conducted by Shafiei et al., P. atlantica gum resin extract showed their anticancer effects against KMBC, PANC-1, CRL-1739, and COLO205 cancer cells through the upregulation of caspase-9, caspase-3, and Bax, as well as the downregulation of Bcl-2 genes[12]. Amiri et al. have also reported that P. atlantica ethanolic extract increased the expression of Bax and caspase-3 genes and down-regulated the Bcl-2 expression in human prostate cancer pc3 cells after 48 h exposure[11].
As a limitation of the study, we didn’t separate the main and effective compounds of the plant that may have anti-cancer effects or explore other possible anti-cancer mechanisms, neither, which will be studied in our further experiment.
In conclusion, our study revealed that P. atlantica methanolic extract could reduce tumor volume, body weight, tumor markers (AFP and CEA), serum level of liver and kidney enzymes, MDA, NO, and TNF-α level; whereas PAME at 50 and 100 mg/kg/ day significantly increased the level of antioxidant enzymes of GPx, CAT, and SOD in EST mice. Therefore, the extract might be considered as an alternative anticancer agent against tumors, however, additional studies especially in the clinical setting are required to confirm this finding.
Conflict of interest statement
The authors declare no conflict of interest.
Acknowledgments
The authors would like to thank the Deanship of Scientific Research at Shaqra University for supporting this work.
Authors’ contributions
AEA and NAA contributed in study design, conceptualization, methodology, and investigation. RHA and SFA performed the experiments and analyzed data. AEA, SFA and NAA supervised the study and wrote the original draft of the manuscript. All authors have read and approved the final manuscript.
| References | | |
| 1. | Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1): 57-70.  |
| 2. | Zhou H, Zou P, Chen ZC, You Y. A novel vicious cycle cascade in tumor chemotherapy. Med Hypotheses 2007; 69(6): 1230-1233. |
| 3. | Chabner BA, Roberts TG. Chemotherapy and the war on cancer. Nat Rev Cancer 2005; 5(1): 65-72. |
| 4. | Diaby V, Tawk R, Sanogo V, Xiao H, Montero AJ. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer. Breast Cancer Res Treat 2015; 151(1): 27-40. |
| 5. | Valenti RB. Chemotherapy education for patients with cancer: A literature review. Clin J Oncol Nurs 2014; 18(6): 637. |
| 6. | Joyce Nirmala M, Samundeeswari A, DeepaSankar P. Natural plant resources in anti-cancer therapy-A review. Res Plant Biol 2011; 1(3): 1-14. |
| 7. | Agarwal N, Majee C, Chakraborthy GS. Natural herbs as anticancer drugs. Int J PharmTech Res 2012; 4(3): 1142-1153. |
| 8. | Bozorgi M, Memariani Z, Mobli M, SalehiSurmaghi MH, Shams-Ardekani MR, Rahimi R. Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): A review of their traditional uses, phytochemistry, and pharmacology. Sci World J 2013; 2013: 219815. |
| 9. | Ahmed ZB, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Vander Heyden Y. Four Pistacia atlantica subspecies (atlantica, cabulica, kurdica and mutica): A review of their botany, ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol 2020; 265: 113329. |
| 10. | Mahjoub F, Rezayat KA, Yousefi M, Mohebbi M, Salari R. Pistacia atlantica Desf. A review of its traditional uses, phytochemicals and pharmacology. J Med Life 2018; 11(3): 180. |
| 11. | Amiri M, Kazerouni F, Namaki S, Tamijani HD, Rahimipour H, Boroumand N, et al. Cytotoxic effects of the ethanol bane skin extract in human prostate cancer Pc3 cells. Iran J Cancer Prev 2016; 9(2): e4755. |
| 12. | Shafiei BH, Shasaltaneh MD, Ghaffari SM, Ahmadian S, Kamarehei M, Raizi GH. An in vitro study on the effect of Pistacia atlantica sub kurdica extract on microtubule proteins: A potential anti-cancer compound. Int J Pharm Sci Res 2015; 6(12): 5029. |
| 13. | Almeer RS, Aref AM, Hussein RA, Othman MS, Abdel Moneim AE. Antitumor potential of berberine and cinnamic acid against solid Ehrlich carcinoma in mice. Anticancer Agents Med Chem 2019; 19(3): 356-364. |
| 14. | Ozaslan M, Karagoz ID, Kilic IH, Guldur ME. Ehrlich ascites carcinoma. Afr J Biotech 2011; 10(13): 2375-2378. |
| 15. | Ezatpour B, Saedi Dezaki E, Mahmoudvand H, Azadpour M, Ezzatkhah F. In vitro and in vivo antileishmanial effects of Pistacia khinjuk against Leishmania tropica and Leishmania major. Evid Based Complement Alternat Med 2015; 2015: 149707. |
| 16. | Nazer MR, Jahanbakhsh S, Ebrahimi K, Niazi M, Sepahvand M, Khatami M, et al. Cytotoxic and antileishmanial effects of various extracts of Capparis spinosa L. Turkish J Pharm Sci 2021; 18(2): 146. |
| 17. | Singleton VL, Orthofer R, Lamuela-Raventó RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods Enzymol 1999; 299: 152-178. |
| 18. | Phuyal N, Jha PK, Raturi PP, Rajbhandary S. Total phenolic, flavonoid contents, and antioxidant activities of fruit, seed, and bark extracts of Zanthoxylum armatum DC. Sci World J 2020; 2020: :8780704. |
| 19. | Broadhurst RB, Jones WT. Analysis of condensed tannins using acidified vanillin. J Sci Food Agric 1978; 29(9): 788-794. |
| 20. | El-Aarag BY, Kasai T, Zahran MA, Zakhary NI, Shigehiro T, Sekhar SC, et al. In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs. Int Immunopharmacol 2014; 21(2): 283-292. |
| 21. | Mahmoudvand H, Kheirandish F, Ghasemi Kia M, Tavakoli Kareshk A, Yarahmadi M. Chemical composition, protoscolicidal effects and acute toxicity of Pistacia atlantica Desf. fruit extract. Nat Prod Res 2016; 30(10): 1208-1211. |
| 22. | Jaganathan SK, Mondhe D, Wani ZA, Pal HC, Mandal M. Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. J Biomed Biotechnol 2010; 2010: 989163-989165. |
| 23. | El-Aarag B, Kasai T, Masuda J, Agwa H, Zahran M, Seno M. Anticancer effects of novel thalidomide analogs in A549 cells through inhibition of vascular endothelial growth factor and matrix metalloproteinase-2. Biomed Pharmacother 2017; 85: 549-555. |
| 24. | Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138. |
| 25. | Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010; 5(1): 51-66. |
| 26. | El-Aarag B, Magdy M, AlAjmi MF, Khalifa SAM, El-Seedi HR. Melittin exerts beneficial effects on paraquat-induced lung injuries in mice by modifying oxidative stress and apoptosis. Molecules 2019; 24(8): 1498. |
| 27. | Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34(3): 497-500. |
| 28. | Selim NM, Elgazar AA, Abdel-Hamid NM, El-Magd MRA, Yasri A, Hefnawy HME, et al. Chrysophanol, physcion, hesperidin and curcumin modulate the gene expression of pro-inflammatory mediators induced by LPS in hepg2: In silico and molecular studies. Antioxidants 2019; 8: 371. |
| 29. | Venugopala KN, Rashmi V, Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int 2013; 2013: 963248. |
| 30. | Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem 2008; 19(6): 347-361. |
| 31. | Hashemi L, Asadi-Samani M, Moradi MT, Alidadi S. Anticancer activity and phenolic compounds of Pistacia atlantica extract. Int J Pharm Phytopharmacol Res 2017; 7(2): 26-31. |
| 32. | Kim JH, Jun KH, Jung H, Park IS, Chin HM. Prognostic value of preoperative serum levels of five tumor markers (Carcinoembryonic antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in gastric cancer. Hepatogastroenterology 2014; 61(131): 863-869. |
| 33. | Saravanan R, Viswanathan P, Pugalendi KV. Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci 2006; 78(7): 713-718. |
| 34. | Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Vamsi ML. Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice. J Pharmacol Sci 2004; 94(2): 177-184. |
| 35. | Abou Zaid OA, Hassanein MR, EL-Senosi YA, EL-Shiekha MF. Biochemical effect of some antioxidant on metabolic changes in experimentally induced tumor in female mice. Benha Veter Med J 2011; 1(1): 52-60. |
| 36. | Hussein SA, Azab ME. Effect of insulin treatment on some metabolic changes on experimentally induced tumor in female mice. Egypt J Biochem Mol Biol 1997; 15: 61-80. |
| 37. | Visconti R, Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Disc Devel 2009; 12(2): 240-245. |
| 38. | Chen W, Jia Z, Pan MH, Anandh Babu PV. Natural products for the prevention of oxidative stress-related diseases: Mechanisms and strategies. Oxid Med Cell Long 2016; 2016: 4628502. |
| 39. | Toul F, Belyagoubi-Benhammou N, Zitouni A, Atik-Bekkara F. Antioxidant activity and phenolic profile of different organs of Pistacia atlantica Desf. subsp. atlantica from Algeria. Nat Prod Res 2017; 31(6): 718-723. |
| 40. | Ben Ahmed Z, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Mangelings D, et al. Seasonal, gender and regional variations in total phenolic, flavonoid, and condensed tannins contents and in antioxidant properties from Pistacia atlantica ssp. leaves. Pharm Biol 2017; 55(1): 1185-1194. |
| 41. | Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev 2006; 25(3): 409-416. |
| 42. | El-Dayem SM, Fouda FM, Ali EH, Motelp BA. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice. Toxicol Ind Health 2013; 29(5): 404-417. |
| 43. | Shen J, Xiao Z, Zhao Q, Li M, Wu X, Zhang L, et al. Anti-cancer therapy with TNFα and IFNγ: A comprehensive review. Cell Prolif 2018; 51(4): e12441. |
| 44. | Letai A. Apoptosis and cancer. Ann Rev Cancer Biol 2017; 1: 275-294. |
| 45. | Koff JL, Ramachandiran S, Bernal-Mizrachi L. A time to kill: Targeting apoptosis in cancer. Int J Mol Sci 2015; 16(2): 2942-2955. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
[Table 1]
|
Search Pubmed for